Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02859597 · ClinicalTrials.gov registry record · NA
Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite
A NA study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02859597 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT02859597, a NA study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.
Interventions
- DEVICE Nasal Cannula
- DEVICE High flow nasal cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-12-28 |
| Est. Completion | 2018-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02859597
The ClinicalTrials.gov registry entry for NCT02859597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nasal Cannula is the first listed.
NCT02859597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02859597 about?
NCT02859597 is a clinical study titled "Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite". This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.
What is the current status of trial NCT02859597?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2016-12-28. Estimated completion is 2018-09-28.
What interventions are being tested in trial NCT02859597?
The interventions under investigation include: Nasal Cannula (DEVICE), High flow nasal cannula (DEVICE).
Who is sponsoring clinical trial NCT02859597?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.